These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 19649940)

  • 1. Antisense oligonucleotides - the way forward.
    Wahlestedt C; Good L
    Curr Opin Drug Discov Devel; 1999 Mar; 2(2):142-6. PubMed ID: 19649940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent advances in the medicinal chemistry of antisense oligonucleotides.
    Uhlmann E
    Curr Opin Drug Discov Devel; 2000 Mar; 3(2):203-13. PubMed ID: 19649851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intranasal antisense therapy: preclinical models with a clinical future?
    Bitko V; Barik S
    Curr Opin Mol Ther; 2007 Apr; 9(2):119-25. PubMed ID: 17458164
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative measurements and rational materials design for intracellular delivery of oligonucleotides.
    Roth CM
    Biotechnol Prog; 2008; 24(1):23-8. PubMed ID: 17887773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overcoming biological barriers to in vivo efficacy of antisense oligonucleotides.
    White PJ; Anastasopoulos F; Pouton CW; Boyd BJ
    Expert Rev Mol Med; 2009 Mar; 11():e10. PubMed ID: 19302730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled delivery of antisense oligonucleotides: a brief review of current strategies.
    Zhao X; Pan F; Holt CM; Lewis AL; Lu JR
    Expert Opin Drug Deliv; 2009 Jul; 6(7):673-86. PubMed ID: 19552611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Making sense of therapeutics using antisense technology.
    Malik R; Roy I
    Expert Opin Drug Discov; 2011 May; 6(5):507-26. PubMed ID: 22646076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel trends in high-throughput screening.
    Mayr LM; Bojanic D
    Curr Opin Pharmacol; 2009 Oct; 9(5):580-8. PubMed ID: 19775937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting FtsZ for antibacterial therapy: a promising avenue.
    Kapoor S; Panda D
    Expert Opin Ther Targets; 2009 Sep; 13(9):1037-51. PubMed ID: 19659446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent progress in oligonucleotide therapeutics: antisense to aptamers.
    Leaman DW
    Expert Opin Drug Discov; 2008 Sep; 3(9):997-1009. PubMed ID: 23506176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for potential toxicity of antiviral therapies.
    Szczech GM; Furman PA
    Curr Opin Drug Discov Devel; 2000 Jan; 3(1):56-62. PubMed ID: 19649838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orotransmucosal drug delivery systems: a review.
    Madhav NV; Shakya AK; Shakya P; Singh K
    J Control Release; 2009 Nov; 140(1):2-11. PubMed ID: 19665039
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current status of malaria chemotherapy and the role of pharmacology in antimalarial drug research and development.
    Na-Bangchang K; Karbwang J
    Fundam Clin Pharmacol; 2009 Aug; 23(4):387-409. PubMed ID: 19709319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of pre-mRNA splicing by antisense oligonucleotides.
    Taylor JK; Dean NM
    Curr Opin Drug Discov Devel; 1999 Mar; 2(2):147-51. PubMed ID: 19649941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Wide QRS complex tachycardia: an old and new problem].
    Oreto G; Luzza F; Satullo G; Donato A; Carbone V; Calabrò MP
    G Ital Cardiol (Rome); 2009 Sep; 10(9):580-95. PubMed ID: 19891250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cellular delivery of antisense oligonucleotides and ribozymes.
    Hughes MD; Hussain M; Nawaz Q; Sayyed P; Akhtar S
    Drug Discov Today; 2001 Mar; 6(6):303-315. PubMed ID: 11257582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural genomics in the post-genomics era - the shapes of things to come.
    Peat TS; Newman JM; Bussiere DE
    Curr Opin Drug Discov Devel; 2000 Jul; 3(4):399-407. PubMed ID: 19649871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Division of Carbohydrate Chemistry--recent developments in oligonucleotide therapeutics.
    Agathangelou P
    IDrugs; 1999 Jun; 2(6):519-20. PubMed ID: 16127605
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing cancer signal transduction pathways with antisense and siRNA oligonucleotides.
    Juliano RL
    NAR Cancer; 2020 Sep; 2(3):zcaa025. PubMed ID: 33015625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular approaches to contraceptive development.
    Natraj U
    J Biosci; 2001 Nov; 26(4 Suppl):407-19. PubMed ID: 11779955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.